Lisata Therapeutics cuts workforce about 72% in reorganization

Reuters2026/08/04 10:11

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Lisata Therapeutics began a corporate reorganization on Aug. 3, 2026, cutting its workforce by about 72% effective immediately.
Move targets lower operating expenses as the company pursues strategic options.
Restructuring costs expected at about $1.2 million, mainly severance and termination benefits, incurred through the quarter ending Sept. 30, 2026.
Executive Vice President of R&D and Chief Medical Officer Kristen K. Buck was terminated; contract provides 12 months base salary and target bonus, COBRA up to 12 months.
Board authorized a $200,000 cash retention bonus for Chief Accounting Officer James Nisco, payable within 30 days of Dec. 31, 2026 subject to continued employment.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Lisata Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001140361-26-031028), on August 04, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Lisata Therapeutics cuts workforce about 72% in reorganization

You may also like

Crypto prices